220 related articles for article (PubMed ID: 35902557)
21. Verteporfin inhibits TGF-β signaling by disrupting the Smad2/3-Smad4 interaction.
Nong J; Shen S; Hong F; Xiao F; Meng L; Li P; Lei X; Chen YG
Mol Biol Cell; 2024 Jul; 35(7):ar95. PubMed ID: 38696259
[TBL] [Abstract][Full Text] [Related]
22. [Aberrant Activation Mechanism of TGF-β Signaling in Epithelial-mesenchymal Transition].
Yuki R
Yakugaku Zasshi; 2021; 141(11):1229-1234. PubMed ID: 34719542
[TBL] [Abstract][Full Text] [Related]
23. Nagilactone E suppresses TGF-β1-induced epithelial-mesenchymal transition, migration and invasion in non-small cell lung cancer cells.
Zhang LL; Jiang XM; Huang MY; Feng ZL; Chen X; Wang Y; Li H; Li A; Lin LG; Lu JJ
Phytomedicine; 2019 Jan; 52():32-39. PubMed ID: 30599910
[TBL] [Abstract][Full Text] [Related]
24. c-Jun N-terminal kinase 1 promotes transforming growth factor-β1-induced epithelial-to-mesenchymal transition via control of linker phosphorylation and transcriptional activity of Smad3.
Velden JL; Alcorn JF; Guala AS; Badura EC; Janssen-Heininger YM
Am J Respir Cell Mol Biol; 2011 Apr; 44(4):571-81. PubMed ID: 20581097
[TBL] [Abstract][Full Text] [Related]
25. Long noncoding RNA LINC01186, regulated by TGF-β/SMAD3, inhibits migration and invasion through Epithelial-Mesenchymal-Transition in lung cancer.
Hao Y; Yang X; Zhang D; Luo J; Chen R
Gene; 2017 Apr; 608():1-12. PubMed ID: 28119085
[TBL] [Abstract][Full Text] [Related]
26. Tumor-Associated Macrophages Derived TGF-β‒Induced Epithelial to Mesenchymal Transition in Colorectal Cancer Cells through Smad2,3-4/Snail Signaling Pathway.
Cai J; Xia L; Li J; Ni S; Song H; Wu X
Cancer Res Treat; 2019 Jan; 51(1):252-266. PubMed ID: 29690747
[TBL] [Abstract][Full Text] [Related]
27. ADAMTS1 induces epithelial-mesenchymal transition pathway in non-small cell lung cancer by regulating TGF-β.
Hu X; Jiang C; Hu N; Hong S
Aging (Albany NY); 2023 Mar; 15(6):2097-2114. PubMed ID: 36947712
[TBL] [Abstract][Full Text] [Related]
28. KIFC1 aggravates non-small-cell lung cancer cell proliferation and metastasis via provoking TGF-β/SMAD signal.
Liu Y; Ye W; Miao X; Wang X
Cell Mol Biol (Noisy-le-grand); 2023 Dec; 69(14):293-299. PubMed ID: 38279416
[TBL] [Abstract][Full Text] [Related]
29. TRIM66 hastens the malignant progression of non-small cell lung cancer via modulating MMP9-mediated TGF-β/SMAD pathway.
Chen W; Zhang Y; Fang Z; Qi W; Xu Y
Cytokine; 2022 May; 153():155831. PubMed ID: 35301175
[TBL] [Abstract][Full Text] [Related]
30. TGF-β/SMAD4-Regulated LncRNA-LINP1 Inhibits Epithelial-Mesenchymal Transition in Lung Cancer.
Zhang C; Hao Y; Wang Y; Xu J; Teng Y; Yang X
Int J Biol Sci; 2018; 14(12):1715-1723. PubMed ID: 30416386
[TBL] [Abstract][Full Text] [Related]
31. PARP-1 induces EMT in non-small cell lung carcinoma cells via modulating the transcription factors Smad4, p65 and ZEB1.
Kumar M; Jaiswal RK; Prasad R; Yadav SS; Kumar A; Yadava PK; Singh RP
Life Sci; 2021 Mar; 269():118994. PubMed ID: 33417952
[TBL] [Abstract][Full Text] [Related]
32. Prostate apoptosis response-4 mediates TGF-β-induced epithelial-to-mesenchymal transition.
Chaudhry P; Fabi F; Singh M; Parent S; Leblanc V; Asselin E
Cell Death Dis; 2014 Feb; 5(2):e1044. PubMed ID: 24503536
[TBL] [Abstract][Full Text] [Related]
33. MicroRNA-539 functions as a tumour suppressor in prostate cancer via the TGF-β/Smad4 signalling pathway by down-regulating DLX1.
Sun B; Fan Y; Yang A; Liang L; Cao J
J Cell Mol Med; 2019 Sep; 23(9):5934-5948. PubMed ID: 31298493
[TBL] [Abstract][Full Text] [Related]
34. Gankyrin promotes epithelial-mesenchymal transition and metastasis in NSCLC through forming a closed circle with IL-6/ STAT3 and TGF-β/SMAD3 signaling pathway.
Wang WP; Sun Y; Lu Q; Zhao JB; Wang XJ; Chen Z; Ni YF; Wang JZ; Han Y; Zhang ZP; Yan XL; Li XF
Oncotarget; 2017 Jan; 8(4):5909-5923. PubMed ID: 27992365
[TBL] [Abstract][Full Text] [Related]
35. A Smad3 and TTF-1/NKX2-1 complex regulates Smad4-independent gene expression.
Isogaya K; Koinuma D; Tsutsumi S; Saito RA; Miyazawa K; Aburatani H; Miyazono K
Cell Res; 2014 Aug; 24(8):994-1008. PubMed ID: 25060702
[TBL] [Abstract][Full Text] [Related]
36. Studying TGF-β Signaling and TGF-β-induced Epithelial-to-mesenchymal Transition in Breast Cancer and Normal Cells.
Zhang J; Thorikay M; van der Zon G; van Dinther M; Ten Dijke P
J Vis Exp; 2020 Oct; (164):. PubMed ID: 33191940
[TBL] [Abstract][Full Text] [Related]
37. Prohaptoglobin inhibits the transforming growth factor-β-induced epithelial-to-mesenchymal transition in vitro by increasing Smad1/5 activation and suppressing the Smad2/3 signaling pathway in SK-Hep1 liver cancer cells.
Oh MK; Joo H; Kim IS
PLoS One; 2022; 17(5):e0266409. PubMed ID: 35580109
[TBL] [Abstract][Full Text] [Related]
38. MicroRNA-527 inhibits TGF-β/SMAD induced epithelial-mesenchymal transition via downregulating SULF2 expression in non-small-cell lung cancer.
Huo W; Zhu XM; Pan XY; Du M; Sun Z; Li ZM
Math Biosci Eng; 2019 May; 16(5):4607-4621. PubMed ID: 31499680
[TBL] [Abstract][Full Text] [Related]
39. Natural alkaloid 8-oxo-epiberberine inhibited TGF-β1-triggred epithelial-mesenchymal transition by interfering Smad3.
Liu X; Zhang Y; Zhou GJ; Hou Y; Kong Q; Lu JJ; Zhang Q; Chen X
Toxicol Appl Pharmacol; 2020 Oct; 404():115179. PubMed ID: 32745479
[TBL] [Abstract][Full Text] [Related]
40. Loss of RAB1B promotes triple-negative breast cancer metastasis by activating TGF-β/SMAD signaling.
Jiang HL; Sun HF; Gao SP; Li LD; Hu X; Wu J; Jin W
Oncotarget; 2015 Jun; 6(18):16352-65. PubMed ID: 25970785
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
